IMAX Corp
IMAX
51.45
+0.87
+1.72%
IMAX Corp
US · IMAX
#2528 by market cap
Listed 2011
51.45
+0.87
+1.72%
Live - 5344 symbols - heartbeat 48s ago
· 2026-10-07 20:28
After-hours
51.45
0.00%
Overnight
51.45
0.00%
- Market cap
- 2.82B
- P/E (TTM)i
- 70.48
- P/Bi
- 7.93
- EPSi
- 0.63
- Div yieldi
- 0.00%
- 52W posi
- 77%
Reader sentiment
Are you bullish or bearish on IMAX?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 4.48, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +16.47% YoY
Margins
- Gross margin
- 60.02%
- Operating margin
- 22.84%
- Net margin
- 8.50%
Key ratios & quality
- Enterprise valuei
- 2.95B
- Altman Z-Scorei
- 4.48
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 374.40M | 395.66M | 137.00M | 254.88M | 300.81M | 374.84M | 352.21M | 410.21M |
| Gross profit | 207.93M | 214.17M | 21.54M | 134.41M | 156.36M | 214.34M | 190.20M | 246.19M |
| Selling & admin expenses | 117.48M | 123.46M | 108.49M | 117.32M | 138.04M | 144.41M | 132.70M | 138.46M |
| Research & development | 13.73M | 5.20M | 5.62M | 6.94M | 5.30M | 10.11M | 5.10M | 5.82M |
| Operating profit | 69.45M | 78.13M | -116.57M | 9.21M | -364.00K | 53.49M | 47.61M | 93.71M |
| Pretax profit | 43.61M | 75.34M | -129.12M | 10.99M | -9.77M | 46.12M | 37.70M | 63.29M |
| Tax | 9.52M | 16.77M | 26.50M | 20.56M | 10.11M | 13.05M | 5.00M | 17.77M |
| Net profit | 33.60M | 58.57M | -157.49M | -9.58M | -19.88M | 33.07M | 32.70M | 45.53M |
| Basic EPS | 0 | 1 | -2 | 0 | 0 | 0 | 0 | 1 |
| Diluted EPS | 0.36 | 0.76 | -2.43 | -0.38 | -0.40 | 0.46 | 0.48 | 0.63 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 86.67M | 91.68M | 106.65M | 125.21M | 81.38M | 102.84M |
| Gross profit | 53.18M | 53.60M | 67.27M | 72.14M | 45.81M | 62.90M |
| Selling & admin expenses | 33.46M | 35.30M | 34.22M | 35.47M | 32.49M | 34.53M |
| Research & development | 1.32M | 1.54M | 1.51M | 1.45M | 1.80M | 1.66M |
| Operating profit | 16.79M | 15.13M | 29.05M | 32.74M | 9.95M | 23.07M |
| Pretax profit | 15.44M | 13.43M | 27.82M | 6.60M | 8.49M | 19.42M |
| Tax | 7.29M | 1.20M | 5.21M | 4.08M | 2.42M | 3.51M |
| Net profit | 8.15M | 12.24M | 22.62M | 2.53M | 6.07M | 15.91M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.04 | 0.20 | 0.37 | 0.01 | 0.08 | 0.27 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 453.17M | 430.30M | 596.02M | 523.75M | 450.83M | 447.88M | 456.70M | 519.99M |
| Cash & ST investments | 141.59M | 109.48M | 317.38M | 189.71M | 97.40M | 76.20M | 100.59M | 151.17M |
| Inventory | 44.56M | 42.99M | 39.58M | 26.92M | 31.53M | 31.58M | 32.84M | 32.51M |
| Total assets | 873.60M | 889.07M | 997.75M | 883.25M | 821.15M | 814.67M | 830.40M | 894.03M |
| Total current liabilities | 274.24M | 245.97M | 513.85M | 211.59M | 249.57M | 227.43M | 209.76M | 209.74M |
| Short-term debt | 37.75M | 18.23M | 305.68M | 2.47M | 36.11M | 22.92M | 36.36M | 34.58M |
| Long-term debt | -- | -- | -- | 223.64M | 226.91M | 229.13M | 229.90M | 244.03M |
| Total liabilities | 274,243,000.00 | 245,974,000.00 | 532,983,000.00 | 452,875,000.00 | 491,386,000.00 | 469,080,000.00 | 452,183,000.00 | 466,298,000.00 |
| Total equity | 599.36M | 643.10M | 464.77M | 430.37M | 329.77M | 345.59M | 378.22M | 427.73M |
| Retained earnings | -85.39M | -40.25M | -202.85M | -234.98M | -293.12M | -292.85M | -274.68M | -239.97M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 468.21M | 490.47M | 510.75M | 519.99M | 518.97M | 543.91M |
| Cash & ST investments | 97.07M | 109.25M | 143.11M | 151.17M | 146.00M | 159.92M |
| Inventory | 31.73M | 36.70M | 41.44M | 32.51M | 35.82M | 39.25M |
| Total assets | 848.30M | 868.58M | 889.57M | 894.03M | 893.15M | 917.90M |
| Total current liabilities | 221.37M | 220.51M | 209.60M | 209.74M | 208.17M | 211.14M |
| Short-term debt | 49.47M | 47.55M | 26.48M | 34.58M | 46.70M | 38.84M |
| Long-term debt | 230.13M | 230.47M | 230.74M | 244.03M | 244.13M | 243.80M |
| Total liabilities | 464,015,000.00 | 463,509,000.00 | 452,866,000.00 | 466,298,000.00 | 464,814,000.00 | 467,465,000.00 |
| Total equity | 384.29M | 405.07M | 436.71M | 427.73M | 428.34M | 450.43M |
| Retained earnings | -272.40M | -261.26M | -240.60M | -239.97M | -235.74M | -230.82M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 109.97M | 90.38M | -23.01M | 6.07M | 17.32M | 58.62M | 70.84M | 127.07M |
| Depreciation & amortization | 57.44M | 62.98M | 52.70M | 56.08M | 56.66M | 60.02M | 65.50M | 62.45M |
| Free cash flow | 53.10M | 39.54M | -32.27M | -11.71M | -15.30M | 25.78M | 29.62M | 85.15M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -78.48M | -35.65M | -41.24M | -23.97M | -83.17M | -26.84M | -17.97M | -1.45M |
| Ending cash balance | 141.59M | 109.48M | 317.38M | 189.71M | 97.40M | 76.20M | 100.59M | 151.17M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 6.95M | 23.23M | 67.51M | 29.37M | 4.03M | 31.99M |
| Depreciation & amortization | 14.91M | 15.90M | 15.61M | 16.03M | 15.24M | 15.68M |
| Free cash flow | -7.67M | 15.81M | 54.78M | 22.24M | -2.90M | 25.88M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | 0 | 0 | -- | -- |
| Ending cash balance | 97.07M | 109.25M | 143.11M | 151.17M | 146.00M | 159.92M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 4.39 | 8.84 | -30.81 | -6.02 | -7.36 | 9.44 | 9.10 | 10.94 |
| ROA %i | 2.63 | 5.32 | -15.24 | -2.37 | -2.68 | 3.10 | 3.17 | 4.04 |
| ROIC %i | 4.25 | 8.50 | -22.34 | -2.51 | -3.48 | 5.41 | 5.72 | 6.46 |
| 5-year avg ROE %i | 6.36 | 5.89 | -2.40 | -4.56 | -6.12 | -5.11 | -5.06 | 3.24 |
| EBIT margin %i | 12.43 | 19.75 | -89.13 | 7.09 | -1.29 | 14.12 | 13.00 | 17.22 |
| FCF / sales %i | 14.18 | 9.99 | -- | -- | -- | 6.88 | 8.41 | 20.76 |
| Current ratioi | 1.65 | 1.75 | 1.16 | 2.48 | 1.81 | 1.97 | 2.18 | 2.48 |
| Quick ratioi | 1.45 | 1.53 | 1.06 | 2.29 | 1.63 | 1.78 | 1.96 | 2.25 |
| Debt / assetsi | 4.32 | 2.05 | 30.64 | 25.60 | 32.03 | 30.94 | 32.06 | 31.16 |
| LT debt / equityi | -- | -- | -- | 62.81 | 86.16 | 83.89 | 76.77 | 72.22 |
| Interest coveragei | 15.95 | 27.97 | -17.42 | 2.55 | -0.66 | 7.76 | 5.66 | 9.60 |
| Revenue CAGR (3Y) %i | 0.05 | 1.59 | -28.87 | -12.03 | -8.73 | 39.86 | 11.38 | 10.89 |
| Net income CAGR (3Y) %i | -25.77 | 17.64 | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | 92.80 | 38.45 | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 9.00 | 11.16 | 12.38 | 10.94 | 11.58 | 12.10 |
| ROA %i | 3.00 | 3.87 | 4.55 | 4.04 | 4.22 | 4.58 |
| ROIC %i | 5.27 | 6.36 | 7.34 | 6.46 | 6.71 | 7.26 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 14.04 | 17.24 | 19.11 | 17.22 | 15.76 | 16.78 |
| FCF / sales %i | 11.13 | 8.09 | 16.82 | 20.76 | 22.21 | 24.03 |
| Current ratioi | 2.12 | 2.22 | 2.44 | 2.48 | 2.49 | 2.58 |
| Quick ratioi | 1.91 | 2.00 | 2.17 | 2.25 | 2.24 | 2.32 |
| Debt / assetsi | 32.96 | 32.01 | 28.92 | 31.16 | 32.56 | 30.79 |
| LT debt / equityi | 76.84 | 71.93 | 66.01 | 72.22 | 72.77 | 68.50 |
| Interest coveragei | 6.36 | 8.24 | 10.06 | 9.60 | 8.56 | 9.32 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Technology products and services is the largest reported line at 63.02% of revenue, across 3 reported segments.
- Content Solutions follows at 33.73%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Technology products and services63.02%
Content Solutions33.73%
All other3.25%
Quote time 2026-10-07 20:28:12 · For reference only, not investment advice and not tailored to your situation.